These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24827844)

  • 1. Macrophages associated with tumors as potential targets and therapeutic intermediates.
    Vinogradov S; Warren G; Wei X
    Nanomedicine (Lond); 2014 Apr; 9(5):695-707. PubMed ID: 24827844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor associated macrophages (TAMs) via nanocarriers.
    Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
    J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of macrophage heterogeneity in human malignant tumors.
    Komohara Y; Jinushi M; Takeya M
    Cancer Sci; 2014 Jan; 105(1):1-8. PubMed ID: 24168081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.
    Lao L; Fan S; Song E
    Adv Exp Med Biol; 2017; 1026():331-370. PubMed ID: 29282692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment.
    Wang Y; Lin YX; Qiao SL; An HW; Ma Y; Qiao ZY; Rajapaksha RP; Wang H
    Biomaterials; 2017 Jan; 112():153-163. PubMed ID: 27768970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.
    Lin Y; Xu J; Lan H
    J Hematol Oncol; 2019 Jul; 12(1):76. PubMed ID: 31300030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy.
    Zhan X; Jia L; Niu Y; Qi H; Chen X; Zhang Q; Zhang J; Wang Y; Dong L; Wang C
    Biomaterials; 2014 Dec; 35(38):10046-57. PubMed ID: 25245263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting macrophages: a novel avenue for cancer drug discovery.
    Kumar S; Ramesh A; Kulkarni A
    Expert Opin Drug Discov; 2020 May; 15(5):561-574. PubMed ID: 32141351
    [No Abstract]   [Full Text] [Related]  

  • 11. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
    Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage regulation of tumor responses to anticancer therapies.
    De Palma M; Lewis CE
    Cancer Cell; 2013 Mar; 23(3):277-86. PubMed ID: 23518347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy.
    Korbelik M; Hamblin MR
    Photochem Photobiol Sci; 2015 Aug; 14(8):1403-9. PubMed ID: 25620672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages and anti-tumor therapies: complex links.
    Belgiovine C; D'Incalci M; Allavena P; Frapolli R
    Cell Mol Life Sci; 2016 Jul; 73(13):2411-24. PubMed ID: 26956893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bi-directional dialog between vascular cells and monocytes/macrophages regulates tumor progression.
    Delprat V; Michiels C
    Cancer Metastasis Rev; 2021 Jun; 40(2):477-500. PubMed ID: 33783686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.
    Komohara Y; Fujiwara Y; Ohnishi K; Takeya M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):180-185. PubMed ID: 26621196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor-conditioned macrophages.
    Maeda A; Digifico E; Andon FT; Mantovani A; Allavena P
    Eur J Immunol; 2019 May; 49(5):801-811. PubMed ID: 30779113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-associated macrophages as treatment targets in oncology.
    Mantovani A; Marchesi F; Malesci A; Laghi L; Allavena P
    Nat Rev Clin Oncol; 2017 Jul; 14(7):399-416. PubMed ID: 28117416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.
    Su CW; Chiang CS; Li WM; Hu SH; Chen SY
    Nanomedicine (Lond); 2014 Jul; 9(10):1499-515. PubMed ID: 25253498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.